Last updated: 2026-01-15 13:54:31 ET
A major exchange-traded fund manager suggests the oil trade won't provide much upside ahead.
BofA analysts are bullish on this German medtech name ahead of its full-year earnings report.
Analyst Mark Mahaney initiated coverage of the social platform with an outperform rating.
Citi's $235 price target implies upside of 32% ahead for shares of Palantir.
Bank of America has upgraded Coinbase's rating on reversing short interest and tax-loss harvesting, while the exchange is broadening its vision to put...
UBS analyst Jay Sole's revised price target of $41, hiked from $26, offers upside of 54% for shares of Gap.
